Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-12 4:17 pm Sale | 2020-12-31 | 13G | La Jolla Pharmaceutical Company LJPC | Sectoral Asset Management Inc | 163,681 0.770% | -1,306,658 (-88.87%) | Filing History |
| 2021-02-11 2:23 pm Sale | 2020-12-31 | 13G | Aprea Therapeutics, Inc. APRE | JANUS HENDERSON GROUP PLC JHG | 0 0.000% | -90,543 (Position Closed) | Filing History |
| 2021-02-10 09:23 am Sale | 2021-02-09 | 13G | Aprea Therapeutics, Inc. APRE | FMR LLC | 1 0.000% | -63,063 (-100.00%) | Filing History |
| 2021-02-08 10:15 am Sale | 2021-02-05 | 13G | Aprea Therapeutics, Inc. APRE | FMR LLC | 63,064 5.953% | -44,057 (-41.13%) | Filing History |
| 2020-11-19 4:27 pm Sale | 2020-11-16 | 13D | Aprea Therapeutics, Inc. APRE | 5AM Ventures IV L.P. | 68,883 6.500% | -33,000 (-32.39%) | Filing History |
| 2020-10-07 5:00 pm Sale | 2020-10-05 | 13D | Aprea Therapeutics, Inc. APRE | 5AM Ventures IV L.P. | 101,883 9.600% | -15,750 (-13.39%) | Filing History |
| 2020-06-15 7:13 pm Sale | 2020-06-11 | 13D | Aprea Therapeutics, Inc. APRE | 5AM Ventures IV L.P. | 117,633 11.200% | -12,250 (-9.43%) | Filing History |
| 2020-05-21 8:38 pm Sale | 2020-05-19 | 13D | Aprea Therapeutics, Inc. APRE | 5AM Ventures IV L.P. | 129,883 12.300% | -12,750 (-8.94%) | Filing History |